Hyphens Pharma International Limited (SGX:1J5)
Singapore · Delayed Price · Currency is SGD 0.3500
-0.0050 (-1.41%)
At close: Jul 27, 2026
SGXC:1J5 Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5.84 | 10.19 | 8.57 | 11.35 | 6.85 |
Depreciation & Amortization | 2.81 | 3.06 | 2.8 | 2.72 | 2.2 |
Loss (Gain) From Sale of Assets | 0.09 | -0.01 | -0.01 | 0 | 0 |
Loss (Gain) From Sale of Investments | - | - | -0.17 | - | - |
Loss (Gain) on Equity Investments | - | - | -0.55 | -0.47 | -0.02 |
Other Operating Activities | 1.35 | 1.3 | -0.77 | 1.13 | 0.47 |
Change in Accounts Receivable | 10.45 | -4.18 | -9.24 | -2.56 | -1.99 |
Change in Inventory | 5.11 | -8.92 | -3.52 | 4.03 | -4.61 |
Change in Accounts Payable | -5 | -0.92 | 9.65 | 0.84 | 3.11 |
Change in Other Net Operating Assets | -1.91 | -0.47 | -1.13 | -0.17 | 0.02 |
Operating Cash Flow | 18.75 | 0.06 | 5.65 | 16.88 | 6.04 |
Operating Cash Flow Growth | 31146.67% | -98.94% | -66.55% | 179.51% | 46.20% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.76 | -1.18 | -0.3 | -0.56 | -0.7 |
Sale of Property, Plant & Equipment | - | 0.01 | 0.01 | 0 | - |
Cash Acquisitions | -3.42 | -0.1 | -0.75 | 0.18 | -14.16 |
Sale (Purchase) of Intangibles | -0.5 | -2 | -0.9 | -0.76 | -0.13 |
Investment in Securities | - | - | - | 0.03 | - |
Other Investing Activities | 0.06 | 0.15 | 0.46 | 0.1 | 0.07 |
Investing Cash Flow | -4.62 | -3.12 | -1.48 | -1.01 | -14.92 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 12.9 | 9.01 | - | 5 | 4.24 |
Long-Term Debt Repaid | -17.77 | -2.82 | -2.5 | -7.64 | -1.47 |
Net Debt Issued (Repaid) | -4.87 | 6.19 | -2.5 | -2.64 | 2.77 |
Repurchase of Common Stock | -0 | -0.09 | - | - | - |
Common Dividends Paid | -4.63 | -2.66 | -14.56 | -2.07 | -1.86 |
Other Financing Activities | -1.21 | -0.34 | -0.21 | 5.86 | -0.1 |
Financing Cash Flow | -10.72 | 3.11 | -17.28 | 1.15 | 0.81 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 3.41 | 0.05 | -13.11 | 17.02 | -8.07 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 17.99 | -1.12 | 5.34 | 16.32 | 5.34 |
Free Cash Flow Growth | - | - | -67.27% | 205.77% | 41.98% |
Free Cash Flow Margin | 10.14% | -0.57% | 3.13% | 10.05% | 4.24% |
Free Cash Flow Per Share | 0.06 | -0.00 | 0.02 | 0.05 | 0.02 |
Levered Free Cash Flow | 17.19 | -7.07 | 2.01 | 14.57 | -0.74 |
Unlevered Free Cash Flow | 17.51 | -6.72 | 2.18 | 14.71 | -0.68 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.36 | 0.34 | 0.21 | 0.24 | 0.1 |
Cash Income Tax Paid | 2.43 | 2.35 | 2.6 | 2.15 | 1.42 |
Change in Working Capital | 8.66 | -14.49 | -4.24 | 2.14 | -3.46 |